Mycoplasma genitalium test kit Aptima®

Chlamydiagonorrhealead

A highly sensitive NAAT that seamlessly integrates into your lab's workflow to confirm M. gen. A highly prevalent STI you can now accurately identify. Mycoplasma genitalium (M. gen) is an often misdiagnosed sexually transmitted infection (STI) with similar clinical presentation to chlamydia, gonorrhea and trichomoniasis.1,2 Testing for M. gen is recommended by the Centers for Disease Control and Prevention (CDC) for patients with persistent or recurrent cervicitis and urethritis, and should be considered for those with pelvic inflammatory disease (PID).3 Avoid Outdated Methods Conventional testing methods such as microscope and culture have made M. gen difficult to identify.3 Prioritize Accuracy A highly sensitive rRNA test is needed for accurate diagnosis, as it provides a more abundant target than DNA.4 Choose the Right Test Each M. gen organism contains 1000s of rRNA copies versus only one copy of DNA, making an RNA-based nucleic acid amplification test (NAAT) more sensitive than a DNA-based test.4 Receiving the Right Diagnosis The Aptima Mycoplasma genitalium assay offers a sensitive, rRNA-based NAAT that can detect characteristically low M. gen bacterial loads.5,6 CDC recommends NAAT to detect M. gen infection3 First FDA-cleared assay for M. gen7 Often Overlooked When there are symptoms, M. gen can present similarly to other urogenital tract bacterial infections. Overlapping symptoms can include abnormal discharge, vaginal irritation and pain during urination or sex.1,2 Adverse Health Outcomes When left untreated, M. gen infections can result in serious health consequences.9